T. Ahles, J. Root, and E. Ryan, Cancer- and Cancer Treatment???Associated Cognitive Change: An Update on the State of the Science, Journal of Clinical Oncology, vol.30, issue.30, pp.3675-3686, 2012.
DOI : 10.1200/JCO.2012.43.0116

T. Ahles, Brain vulnerability to chemotherapy toxicities, Psycho-Oncology, vol.153, issue.11, pp.1141-1148, 2012.
DOI : 10.1002/pon.3196

A. Hurria, K. Togawa, and S. Mohile, Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study, Journal of Clinical Oncology, vol.29, issue.25, pp.3457-3465, 2011.
DOI : 10.1200/JCO.2011.34.7625

M. Lange, O. Rigal, and C. B. , Cognitive dysfunctions in elderly cancer patients: A new challenge for oncologists, Cancer Treatment Reviews, vol.40, issue.6, pp.810-817, 2014.
DOI : 10.1016/j.ctrv.2014.03.003

C. Adams-price, L. Morse, and G. Cross, The Effects of Chemotherapy on Useful Field of View (UFOV) in Younger and Older Breast Cancer Patients, Experimental Aging Research, vol.14, issue.2, pp.220-234, 2009.
DOI : 10.1159/000082199

B. Eberhardt, S. Dilger, and F. Musial, Short-term monitoring of cognitive functions before and during the first course of treatment, Journal of Cancer Research and Clinical Oncology, vol.14, issue.4, pp.234-240, 2006.
DOI : 10.1007/s00432-005-0070-8

A. Hurria, C. Rosen, and C. Hudis, Cognitive Function of Older Patients Receiving Adjuvant Chemotherapy for Breast Cancer: A Pilot Prospective Longitudinal Study, Journal of the American Geriatrics Society, vol.11, issue.6, pp.925-931, 2006.
DOI : 10.1111/j.1532-5415.2006.00732.x

M. Lange, G. B. Noal, and S. , Baseline cognitive functions among elderly patients with localised breast cancer, European Journal of Cancer, vol.50, issue.13, pp.2181-2189, 2014.
DOI : 10.1016/j.ejca.2014.05.026
URL : https://hal.archives-ouvertes.fr/inserm-01067444

C. Jansen, B. Cooper, and M. Dodd, A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients, Supportive Care in Cancer, vol.1, issue.10, pp.1647-1656, 2011.
DOI : 10.1007/s00520-010-0997-4

J. Wefel, R. Lenzi, and R. Theriault, The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma, Cancer, vol.16, issue.11, pp.2292-2299, 2004.
DOI : 10.1002/cncr.20272

J. Fardell, J. Zhang, D. Souza, and R. , The impact of sustained and intermittent docetaxel chemotherapy regimens on cognition and neural morphology in healthy mice, Psychopharmacology, vol.24, issue.Suppl 2, pp.841-852, 2014.
DOI : 10.1007/s00213-013-3301-8

T. Ahles, A. Saykin, and B. Mcdonald, Longitudinal Assessment of Cognitive Changes Associated With Adjuvant Treatment for Breast Cancer: Impact of Age and Cognitive Reserve, Journal of Clinical Oncology, vol.28, issue.29, pp.4434-4440, 2010.
DOI : 10.1200/JCO.2009.27.0827

S. Deprez, F. Amant, and A. Smeets, Longitudinal Assessment of Chemotherapy-Induced Structural Changes in Cerebral White Matter and Its Correlation With Impaired Cognitive Functioning, Journal of Clinical Oncology, vol.30, issue.3, pp.274-281, 2012.
DOI : 10.1200/JCO.2011.36.8571

K. Hodgson, A. Hutchinson, and C. Wilson, A meta-analysis of the effects of chemotherapy on cognition in patients with cancer, Cancer Treatment Reviews, vol.39, issue.3, pp.297-304, 2013.
DOI : 10.1016/j.ctrv.2012.11.001

H. Jim, K. Phillips, and S. Chait, Meta-Analysis of Cognitive Functioning in Breast Cancer Survivors Previously Treated With Standard-Dose Chemotherapy, Journal of Clinical Oncology, vol.30, issue.29, pp.3578-3587, 2012.
DOI : 10.1200/JCO.2011.39.5640

V. Koppelmans, M. Breteler, and W. Boogerd, Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant Chemotherapy, Journal of Clinical Oncology, vol.30, issue.10, pp.1080-1086, 2012.
DOI : 10.1200/JCO.2011.37.0189

D. Cardebat, B. Doyon, and M. Puel, Formal and semantic lexical evocation in normal subjects: Performance and dynamics of production as a function of sex, Acta Neurol Belg, vol.90, pp.207-217, 1990.

R. Reitan, VALIDITY OF THE TRAIL MAKING TEST AS AN INDICATOR OF ORGANIC BRAIN DAMAGE, Perceptual and Motor Skills, vol.19, issue.3, pp.271-276, 1958.
DOI : 10.2466/pms.1958.8.3.271

A. Rey, S. Adam, and A. Agniel, Manual of Copy and Memory Reproduction Test of Complex Geometric Figures] Paris: ´ Editions Centre de Psychologie Appliqú ee; 1959. 24 The Psychological Corporation, Marseille: Solal, 2004. 25. Wechsler D.Wechsler Adult Intelligence Scale- III, 1997.

F. Joly, M. Lange, and O. Rigal, French version of the Functional Assessment of Cancer Therapy???Cognitive Function (FACT-Cog) version 3, Supportive Care in Cancer, vol.22, issue.12, pp.3297-3305, 2012.
DOI : 10.1007/s00520-012-1439-2

L. Wagner, J. Sweet, and Z. Butt, Measuring patient self-reported cognitive function: Development of the Functional Assessment of Cancer Therapy?Cognitive Function Instrument An inventory for measuring depression, J Support Oncol Arch Gen Psychiatry, vol.74, pp.32-39, 1961.

S. Spielberger, S. Yellen, D. Cella, and K. Webster, Manual for the State-Trait Anxiety Inventory (STAI) Palo Alto, CA: Consulting Psychologists Press; 1983. 30 Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system, J Pain Symptom Manage, vol.13, pp.63-74, 1997.

J. Clément, R. Nassif, L. ´. , and J. , Development and contribution to the validation of a brief French version of the Yesavage Geriatric Depression Scale], Encephale, vol.23, pp.91-99, 1997.

M. Lawton and E. Brody, ASSESSMENT OF OLDER PEOPLE, Nursing Research, vol.19, issue.3, pp.179-186, 1969.
DOI : 10.1097/00006199-197005000-00029

S. Katz, T. Downs, and H. Cash, Progress in development of the index of ADL Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation, Gerontologist J Chronic Dis, vol.1040, issue.34, pp.20-30373, 1970.

K. Duff, Evidence-Based Indicators of Neuropsychological Change in the Individual Patient: Relevant Concepts and Methods, Archives of Clinical Neuropsychology, vol.27, issue.3, pp.248-261, 2012.
DOI : 10.1093/arclin/acr120

G. Iverson, Interpreting change on the WAIS-III/WMS-III in clinical samples, Archives of Clinical Neuropsychology, vol.16, issue.2, pp.183-191, 2001.
DOI : 10.1093/arclin/16.2.183

D. Osoba, G. Rodrigues, and J. Myles, Interpreting the significance of changes in health-related quality-of-life scores., Journal of Clinical Oncology, vol.16, issue.1, pp.139-144, 1998.
DOI : 10.1200/JCO.1998.16.1.139

M. Folstein, S. Folstein, and P. Mchugh, ???Mini-mental state???, Journal of Psychiatric Research, vol.12, issue.3, pp.189-98, 1975.
DOI : 10.1016/0022-3956(75)90026-6

V. Jenkins, V. Shilling, and G. Deutsch, A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer, British Journal of Cancer, vol.4, issue.6, pp.828-834, 2006.
DOI : 10.1016/S0885-3924(96)00274-6

V. Shilling, V. Jenkins, and R. Morris, The effects of adjuvant chemotherapy on cognition in women with breast cancer???preliminary results of an observational longitudinal study, The Breast, vol.14, issue.2, pp.142-150, 2005.
DOI : 10.1016/j.breast.2004.10.004

A. Hurria, S. Patel, and J. Mortimer, The effect of aromatase inhibition on the cognitive function of older patients with breast cancer Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review, Clin Breast Cancer Cancer Treat Rev, vol.1438, pp.132-140, 2012.

B. Reisberg, M. Shulman, and C. Torossian, Outcome over seven years of healthy adults with and without subjective cognitive impairment, Alzheimer's & Dementia, vol.6, issue.1
DOI : 10.1016/j.jalz.2009.10.002

F. Jessen, R. Amariglio, and M. Van-boxtel, A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease, Alzheimer's & Dementia, vol.10, issue.6, pp.844-852, 2014.
DOI : 10.1016/j.jalz.2014.01.001

H. Jim, K. Donovan, and B. Small, Cognitive functioning in breast cancer survivors: A controlled comparison, Cancer, vol.95, issue.8, pp.1776-1783, 2009.
DOI : 10.1002/cncr.24192

K. Donovan, B. Small, and M. Andrykowski, Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma, Cancer, vol.30, issue.11, pp.2499-2507, 2005.
DOI : 10.1002/cncr.21482

M. Mehlsen, A. Pedersen, and A. Jensen, No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy, Psycho-Oncology, vol.47, issue.3, pp.248-257, 2009.
DOI : 10.1002/pon.1398

J. Debess, J. Riis, and M. Engebjerg, Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study, Breast Cancer Research and Treatment, vol.31, issue.1, pp.91-100, 2010.
DOI : 10.1007/s10549-010-0756-8
URL : https://hal.archives-ouvertes.fr/hal-00519326

F. Tager, P. Mckinley, and F. Schnabel, The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study, Breast Cancer Research and Treatment, vol.9, issue.3, pp.25-34, 2010.
DOI : 10.1007/s10549-009-0606-8

B. Collins, J. Mackenzie, and A. Stewart, Cognitive effects of chemotherapy in postmenopausal breast cancer patients 1 year after treatment Neurobiological basis of chemotherapy-induced cognitive impairment: A review of rodent research Longitudinal study of cognitive dysfunctions induced by adjuvant chemotherapy in colon cancer patients, Psychooncology Neurosci Biobehav Rev Support Care Cancer, vol.183522, pp.134-143, 2009.

A. Hurria, S. Goldfarb, and C. Rosen, Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907 Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective, Breast Cancer Res Treat Breast Cancer Res Treat, vol.13998, pp.607-616, 2006.